Low striatal D2 receptor binding as assessed by [I-123]IBZM SPECT in patients with writer's cramp

被引：24
|
作者：
Horstink, CA
Praamstra, P
Horstink, MWIM
Berger, HJC
Booij, J
VanRoyen, EA
机构：
[1] UNIV NIJMEGEN HOSP,DEPT NUCL MED,NL-6500 HB NIJMEGEN,NETHERLANDS
[2] UNIV AMSTERDAM,ACAD MED CTR,DEPT NEUROL,NL-1105 AZ AMSTERDAM,NETHERLANDS
[3] UNIV AMSTERDAM,ACAD MED CTR,DEPT MED PSYCHOL,NL-1105 AZ AMSTERDAM,NETHERLANDS
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 1997年 / 62卷 / 06期
关键词：
D O I：
10.1136/jnnp.62.6.672-a
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：672 / 673
页数：2
相关论文
共 50 条
  • [1] A case of Cotard syndrome:: 123I-IBZM SPECT imaging of striatal D2 receptor binding
    De Risio, S
    De Rossi, G
    Sarchiapone, M
    Camardese, G
    Carli, V
    Cuomo, C
    Satta, MA
    Di Giuda, D
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2004, 130 (01) : 109 - 112
  • [2] INDIVIDUAL VARIATION OF DOPAMINE D2 RECEPTORS WITH I-123 IBZM SPECT
    COPPOLA, R
    WATSKY, E
    WEINBERGER, DR
    BIOLOGICAL PSYCHIATRY, 1994, 35 (09) : 687 - 687
  • [3] In vivo effects on striatal dopamine D2 receptor binding by the new atypical antipsychotic drug olanzapine:: An [I-123]IBZM SPECT study.
    Dresel, S
    Tatsch, K
    Rossmüller, B
    Mager, T
    Hahn, K
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 82P - 82P
  • [4] 123I-IBZM SPECT assessed striatal D2 receptor occupancy and relationship to pharmacokinetics in stabilized schizophrenic patients on olanzapine and risperidone
    Catafau, A. M.
    Penengo, M. M.
    Nucci, G.
    Bullich, S.
    Suarez-Pinera, M.
    Corripio, I.
    Parellada, E.
    Garcia-Ribera, C.
    Pavia, J.
    Ros, D.
    Perich, J.
    Merlo-Pich, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S291 - S291
  • [5] Cortical and Subcortical Patterns of I-123 Iodobenzamide SPECT in Striatal D2 Receptor Parkinsonisms
    Pifarre, Paloma
    Cuberas, Gemma
    Hernandez, Jorge
    Lorenzo, Carles
    Miquel, Francesc
    Castell-Conesa, Joan
    CLINICAL NUCLEAR MEDICINE, 2010, 35 (04) : 228 - 233
  • [6] Striatal D2 receptor blockade predicted EPS with novel antipsychotics:: A [123I] IBZM SPECT
    Tauscher, J
    Küfferle, B
    Barnas, C
    Fischer, P
    Tauscher-Wisniewski, S
    Asenbaum, S
    Brücke, T
    Kasper, S
    BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 14S - 14S
  • [7] SPECT BRAIN DOPAMINE D2 RECEPTOR IMAGING IN HUMANS WITH [I-123] IBZM ADMINISTERED AS A CONSTANT INFUSION
    SEIBYL, J
    BALDWIN, R
    ZEAPONCE, Y
    ABI-DARGHAM, A
    GIORGIANNI, JA
    OFFORD, SJ
    CHARNEY, D
    HOFFER, P
    INNIS, RB
    JOURNAL OF NUCLEAR MEDICINE, 1993, 34 (05) : P109 - P109
  • [8] Striatal D2 receptor binding in 22q11 deletion syndrome: an [123I]IBZM SPECT study
    Boot, E.
    Booij, J.
    Zinkstok, J. R.
    de Haan, L.
    Linszen, D. H.
    Baas, F.
    Van Amelsvoort, T. A.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (10) : 1525 - 1531
  • [9] Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats
    Scherfler, C
    Scholz, SW
    Donnemiller, E
    Decristoforo, C
    Oberladstätter, M
    Stefanova, N
    Diederen, E
    Virgolini, I
    Poewe, W
    Wenning, GK
    NEUROIMAGE, 2005, 24 (03) : 822 - 831
  • [10] Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT:: a comparative study with olanzapine
    Schmitt, GJE
    Meisenzahl, EM
    Dresel, S
    Tatsch, K
    Rossmüller, B
    Frodl, T
    Preuss, UW
    Hahn, K
    Möller, HJ
    JOURNAL OF PSYCHOPHARMACOLOGY, 2002, 16 (03) : 200 - 206
12345